Search Results - "Chazarreta, Carlos D."

Five-Test Simple Scheme for Species-Level Identification of Clinically Significant Coagulase-Negative Staphylococci by DE PAULIS, Adriana N, PREDARI, Silvia C, CHAZARRETA, Carlos D, SANTOIANNI, Jorge E

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status by Heller, Paula G., Lev, Paola R., Salim, Juan P., Kornblihtt, Laura I., Goette, Nora P., Chazarreta, Carlos D., Glembotsky, Ana C., Vassallu, Patricia S., Marta, Rosana F., Molinas, Felisa C.

“…: Objective:  JAK2V617F mutation rate in granulocytes from essential thrombocythemia (ET) patients ranges from 12% to 57%. Our aim was to evaluate the…”
Get full text

Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia by Salim, Juan P., Goette, Nora P., Lev, Paola R., Chazarreta, Carlos D., Heller, Paula G., Alvarez, Clarisa, Molinas, Felisa C., Marta, Rosana F.

“…Summary This study investigated the involvement of chemokines including stromal derived factor 1 (SDF‐1), interleukin 8 (IL‐8), growth‐related oncogene alpha…”
Get full text

Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia by Goette, Nora P, Lev, Paola R, Heller, Paula G, Glembotsky, Ana C, Chazarreta, Carlos D, Salim, Juan P, Molinas, Felisa C, Marta, Rosana F

“…Objective In a previous study, we found increased plasma soluble receptor for interleukin-6 (sIL-6R) levels in patients with essential thrombocythemia (ET)…”
Get full text

Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets by Glembotsky, Ana C., Korin, Laura, Lev, Paola R., Chazarreta, Carlos D., Marta, Rosana F., Molinas, Felisa C., Heller, Paula G.

“…Objectives:  To evaluate the frequency of MPL W515L, W515K and S505N mutations in essential thrombocythemia (ET) and primary myelofibrosis (PMF) and to…”
Get full text

Normal platelets possess the soluble form of IL-6 receptor by Marta, Rosana F., Goette, Nora P., Lev, Paola R., Chazarreta, Carlos D., Pirola, Carlos J., Molinas, Felisa C.

“…Interleukin 6 is a multifunctional cytokine that exerts its biological activity through binding to an 80 Kd specific receptor (IL-6Rα) and a 130 Kd…”
Get full text

Screening for MPL mutations in Essential Thrombocythemia and Primary Myelofibrosis: Normal Mpl Expression and Absence of Constitutive STAT3 and STAT5 Activation in MPLW515L-Positive Platelets by Korin, Laura, Glembotsky, Ana C, Lev, Paola R, Chazarreta, Carlos D, Marta, Rosana F, Molinas, Felisa C., Heller, Paula Graciela

“…Abstract 3910 Poster Board III-846 The identification of exon 10 MPL mutations has begun to unravel the pathogenesis of JAK2V617F-negative essential…”
Get full text

Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPL W515L‐positive platelets by Glembotsky, Ana C., Korin, Laura, Lev, Paola R., Chazarreta, Carlos D., Marta, Rosana F., Molinas, Felisa C., Heller, Paula G.

“…Abstract Objectives:  To evaluate the frequency of MPL W515L, W515K and S505N mutations in essential thrombocythemia (ET) and primary myelofibrosis (PMF) and…”
Get full text

Decreased CXCR4 mRNA Levels and Abnormal SDF-1 Response in Platelets from Essential Thrombocythemia by Salim, Juan P., Marta, Rosana F., Goette, Nora P., Chazarreta, Carlos D., Molinas, Felisa C.

“…Chemokines are soluble mediators implicated in a wide range of physiologic and pathologic processes including megakaryocytic development and platelet…”
Get full text

Anti-Apoptotic Effect of Soluble IL-6 Receptor on Megakaryocytic Lineage in Physiologic Conditions and Essential Thrombocythemia by Chazarreta, Carlos D., Goette, Nora P., Salim, Juan P., Lev, Paola R., Kornblihtt, Laura I., Molinas, Felisa C., Marta, Rosana F.

“…Interleukin 6 (IL-6) plays a stimulatory role in megakaryocytic development acting through a specific receptor (IL-6Ra) and a signal transducing unit, gp130. A…”
Get full text

JAK2 V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status by Heller, Paula G., Lev, Paola R., Salim, Juan P., Kornblihtt, Laura I., Goette, Nora P., Chazarreta, Carlos D., Glembotsky, Ana C., Vassallu, Patricia S., Marta, Rosana F., Molinas, Felisa C.

“…Objective:  JAK2 V617F mutation rate in granulocytes from essential thrombocythemia (ET) patients ranges from 12% to 57%. Our aim was to evaluate the frequency…”
Get full text